Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine and Low-dose Cytarabine in Newly Diagnosed Elderly AML
NCT02985372Phase 3Unknown
- Start
- Dec 2016
- Primary completion
- Dec 2018
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of decitabine in acute myeloid leukemia (AML). Status: unknown.
02
Drugs
decitabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT02985372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02985372.